Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS

BACKGROUND: The COVID-19 pandemic reached Germany in spring 2020. No proven treatment for SARS-CoV-2 was available at that time, especially for severe COVID-19-induced ARDS. We determined whether the infusion of mesenchymal stromal cells (MSCs) would help to improve pulmonary function and overall ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Häberle, Helene, Magunia, Harry, Lang, Peter, Gloeckner, Henning, Körner, Andreas, Koeppen, Michael, Backchoul, Tamam, Malek, Nisar, Handgretinger, Rupert, Rosenberger, Peter, Mirakaj, Valbona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145440/
https://www.ncbi.nlm.nih.gov/pubmed/33663244
http://dx.doi.org/10.1177/0885066621997365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145440/
https://www.ncbi.nlm.nih.gov/pubmed/33663244
http://dx.doi.org/10.1177/0885066621997365

Ejemplares similares